Reoperative surgery for early- and late-onset prosthetic valve endocarditis: temporal trends and outcomes
Interdisciplinary CardioVascular and Thoracic Surgery · 29.03.2025 · 40 (4)
DOI: 10.1093/icvts/ivaf096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 11.04.2025. Verfasst von Pradeep Narayan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Surgery, Narayana Health, Kolkata, India. Hauptthemen laut MEDLINE: Reoperation, Heart Valve Prosthesis, Prosthesis-Related Infections, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVES Prosthetic valve endocarditis (PVE) remains a serious complication following aortic valve replacement, with varying outcomes based on timing of presentation. This study investigated the relationship between timing of reoperation and outcomes in PVE patients using a nationwide database, while examining temporal trends and identifying mortality risk factors. METHODS We analysed 406 patients who underwent reoperative surgery for PVE between 1996 and 2019 across the United Kingdom using the National Institute of Cardiovascular Outcomes Research database. Patients were categorized into early (≤1 year, n = 131) and late (>1 year, n = 275) reoperation groups. Propensity score matching was performed to compare outcomes, and multivariable analysis identified mortality predictors. RESULTS The overall incidence of reoperative surgery for PVE increased over the study period, while the proportion of early-onset PVE decreased from 85.7% in 1998 to 20% in 2019. In matched groups (113 pairs), early reoperation cases required longer cardiopulmonary bypass (135 vs 122 min, P = 0.005) and cross-clamp times (95 vs 88 min, P = 0.011), with extended hospital stays (18.5 vs 14.0 days, P = 0.006). Overall mortality was 8.4%, with an early mortality of 10.8% opposed to 6.2% in late cases (P = 0.338; Lasso AUC: 0.746). Age emerged as the strongest predictor of mortality (OR: 1.14, 95% CI: 1.05–1.27, P = 0.0). CONCLUSIONS This nationwide analysis demonstrates improved PVE outcomes compared to historical data, with overall mortality of 8.4%. While early reoperations were associated with more complex procedures and longer hospital stays, mortality rates were statistically similar. Age remains the primary determinant of mortality risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiac Surgery, Narayana Health, Kolkata, India.
- Cardiac Surgery, Bristol Heart Institute, Bristol University, Bristol, UK.
ORCID-Profile: Pradeep Narayan, Tim Dong, Jeremy Chan, Shubhra Sinha, Daniel P Fudulu, Gianni D Angelini
Zitieren
APA
Narayan, P., Dong, T., Chan, J., Tan, C., Aydin, T., Sinha, S., Fudulu, D. P., & Angelini, G. D. (2025). Reoperative surgery for early- and late-onset prosthetic valve endocarditis: temporal trends and outcomes. Interdisciplinary CardioVascular and Thoracic Surgery, 40(4). https://doi.org/10.1093/icvts/ivaf096
Vancouver
Narayan P, Dong T, Chan J, Tan C, Aydin T, Sinha S, et al. Reoperative surgery for early- and late-onset prosthetic valve endocarditis: temporal trends and outcomes. Interdisciplinary CardioVascular and Thoracic Surgery. 2025;40(4). doi:10.1093/icvts/ivaf096
BibTeX
@article{Narayan2025,
author = {Narayan, Pradeep and Dong, Tim and Chan, Jeremy and Tan, Charles and Aydin, Tugba and Sinha, Shubhra and Fudulu, Daniel P and Angelini, Gianni D},
title = {Reoperative surgery for early- and late-onset prosthetic valve endocarditis: temporal trends and outcomes},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2025},
volume = {40},
number = {4},
doi = {10.1093/icvts/ivaf096}
}
EUVIMED